The role of microRNAs in angiogenesis

Joanna Bujak, Patrycja Kopytko, Małgorzata Lubecka, Katarzyna Sokołowska, Maciej Tarnowski

Abstract


Angiogenesis is the process that leads to the formation of new blood vessels. Under physiological conditions it occurs, inter alia, during corpus luteum formation and in some stages of the menstrual cycle. However, angiogenesis plays an essential role in many pathological conditions, particularly cancer. New blood vessel formation provides cancer cells with oxygen and essential nutrients, which stimulates tumor growth and facilitates its metastasis. Increasing evidence indicates that angiogenesis is regulated by microRNAs (miRNAs), which are small non-coding RNA molecules of 19–25 nucleotides. The main function of miRNAs is post-transcriptional regulation of gene expression, which controls many key biological processes, including cell proliferation, differentiation and migration. Endothelial miRNAs, known as angiomiRs, are presumably involved in tumor development and angiogenesis through regulation of pro- and antiangiogenic factors. To date, the miRNAs that stimulate angiogenesis are: miR-9, miR-27a, miR-30d, miR0-130b, miR-139, miR-146a, miR-150, miR-155, miR-200c, miR-296 and miR-558. Conversely, miRNAs that inhibit angiogenesis are: miR-145, miR-519c, miR-22, miR-20a, miR-92, miR-7b, miR-221, miR-222, miR-328 and miR-101.


Keywords


miRNA; angiogenesis; cancer; RNA; interference

Full Text:

PDF

References


Kurzyk A. Angiogeneza – możliwości, problemy, perspektywy. Post Bioch 2015;61(1):25-34.

Banyś A, Bułaś L, Długosz E, Szulc-Musiał B, Jankowski A. Angiogeneza w chorobie nowotworowej. Patofizjologia 2009;65(4):247-50.

Tomczyk M, Nowak W, Jaźwa A. Śródbłonek w fizjologii i patogenezie chorób. Post Bioch 2013;59(4):357-64.

Szala S, Jarosz M. Nowotworowe naczynia krwionośne. Post Hig 2011;65:437-46.

Sacewicz I, Wiktorska M, Wysocki T, Niewarowska J. Mechanizmy angiogenezy nowotworowej. Post Hig 2009;63:159-68.

Szala S. Angiogeneza i immunosupresja: jin i jang progresji nowotworów? Post Hig 2009;63:598-612.

Suarez Y, Sessa WC. MicroRNAs as novel regulators of angiogenesis. Circ Res 2009;104(4):442-54.

Filip A. MikroRNA: nowe mechanizmy regulacji ekspresji genów. Post Bioch 2007;53(4):413-9.

Du T, Zamore PD. microPrimer: the biogenesis and function of microRNA. Development 2005;132(21):4645-52.

Pillai RS. MicroRNA function: Multiple mechanisms for a tiny RNA? RNA 2005;11(12):1753-61.

Grenda A, Budzyński M, Filip AA. Biogeneza cząsteczek mikroRNA oraz ich znaczenie w powstawaniu i przebiegu wybranych zaburzeń hematologicznych. Post Hig 2013;67:174-85.

Król J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010;11(9):597-610.

Bujak J, Kopytko P, Lubecka M. miRNA markerami chorób nowotworowych. Nauka, Badania i Doniesienia Naukowe 2017;1:269-77.

Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 2005;6(5):376-85.

Hukowska-Szematowicz B, Deptuła W. Biologiczna rola mikroRNA (miRNA) – nowe dane. Post Biol Komórki 2010;37(3):585-97.

John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human microRNA targets. PLoS Biol 2004;2(11):e363.

Zeng Y, Wagner EJ, Cullen BR. Both natural and designed microRNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell 2002;9(6):1327-33.

Zhuang G, Wu X, Jiang Z, Kasman I, Yao J, Guan Y, et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J 2012;31(17):3513-23.

Wang YL, Gong WG, Yuan QL. Effects of miR-27a upregulation on thyroid cancer cells migration, invasion, and angiogenesis. Genet Mol Res 2016;15(4):1-10. doi:10.4238/gmr15049070.

Lin ZY, Chen G, Zhang YQ, He HC, Liang YX, Ye JH, et al. MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer. Mol Cancer 2017;16(1):48. doi:10.1186/s12943-017-0615-x.

Colangelo T, Fucci A, Votino C, Sabatiano L, Pancione M, Laudanna C, et al. MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer. Neoplasia 2013;15(9):1086-99.

Li L, Li B, Chen D, Liu L, Huang C, Lu Z, et al. miR-139 and miR-200c regulate pancreatic cancer endothelial cell migration and angiogenesis. Oncol Rep 2015;34(1):51-8.

Luo HN, Wang ZH, Sheng Y, Zhang Q, Yan J, Hou J, et al. miR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells. Med Oncol 2014;31(1):789. doi:10.1007/s12032-013-0789-z.

Chuang TD, Panda H, Luo X, Chegini N. miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5. Endocr Relat Cancer 2012;19(4):541-56.

Zhu K, Pan Q, Zhang X, Kong LQ, Fan J, Dai Z, et al. MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression. Carcinogenesis 2013;34(9):2071-9.

Bolat F, Kayaselcuk F, Nursal TZ, Yagmurdur MC, Bal N, Demirhan B. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters.

J Exp Clin Cancer Res 2006;25(3):365-72.

Liu Y, Zhao L, Li D, Yin Y, Zhang CY, Li J, et al. Microvesicle-delivery miR-150 promotes tumorigenesis by up-regulating VEGF, and the neutralization of miR-150 attenuate tumor development. Protein Cell 2013;4(12):932-41.

Markowska A, Jaszczyńska-Nowinka K, Kaysiewicz J, Makówka A, Markowska J. Angiogeneza w złośliwych nowotworach ginekologicznych. Curr Gynecol Oncol 2015,13(4):256-62.

Baczyńska D, Michałowska D, Witkiewicz W. Rola mikroRNA w chorobach niedokrwiennych – wpływ na regulację procesów zapalnych, apoptozy i angiogenezy. Prz Lek 2014;70(3):135-42.

Matsui J, Wakabayashi T, Asada M, Yoshimatsu K, Okada M. Stem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells. J Biol Chem 2004;279(18):18600-7.

Poliseno L, Tuccoli A, Mariani L, Evangelista M, Citti L, Woods K, et al. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 2006;108(9):3068-71.

Suárez Y, Fernández-Hernando C, Pober JS, Sessa WC. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res 2007;100(8):1164-73.

Yamakuchi M, Yagi S, Ito T, Lowenstein CJ. MicroRNA-22 regulates hypoxia signaling in colon cancer cells. PLoS One 2011;6(5):e20291.

Hua Z, Lv Q, Ye W, Wong CK, Cai G, Gu D, et al. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 2006;1: e116.

Umezu T, Imanishi S, Azuma K, Kobayashi C, Yoshizawa S, Ohyashiki K, et al. Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis. Blood Adv 2017;1(13):812-23.

Xu Q, Liu LZ, Qian X, Chen Q, Jiang Y, Li D, et al. MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res 2012;40(2):761-74.

Cha ST, Chen PS, Johansson G, Chu CY, Wang MY, Jeng YM, et al. MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis. Cancer Res 2010;70(7):2675-85.




DOI: https://doi.org/10.21164/pomjlifesci.631

Copyright (c) 2019 Joanna Bujak, Patrycja Kopytko, Małgorzata Lubecka, Katarzyna Sokołowska, Maciej Tarnowski

License URL: https://creativecommons.org/licenses/by-nc-nd/3.0/pl/